Objectives: The spatial proximity of adipose depots to secondary lymph nodes allows a unique relation between the two systems. Obesity, predominately visceral adiposity, links to numerous diseases; hence, we postulate that secondary lymphatics within this region contributes to disease risk.
| INTRODUCTION
It is currently estimated that ~70% of adults in the United States are overweight, and a striking half of those are further categorized as obese. 1 Obesity is a precursor for a number of chronic diseases and increases the risk of poorer prognosis in many immune-mediated conditions. [2] [3] [4] [5] Adipose tissue dysregulation is a fundamental driver of the comorbidities associated with obesity. 6 In particular, the dysregulation in and accumulation of visceral adipose tissue (fat stored in the intra-abdominal cavity among the visceral organs that drains to the portal vein) 7, 8 have a greater association with obesity-related comorbidities than subcutaneous adipose tissue (fat stored between the muscle and skin). [9] [10] [11] Inflammation, induced by excessive adipose tissue accumulation, appears to link obesity to disease and immune risk. [12] [13] [14] Hence, the increased propensity for individuals with visceral obesity to experience comorbidities may be linked to the increased capacity of this depot to induce inflammation. 15 This would indicate that distinct adipose tissue depots might differentially contribute to processes that regulate obesity-induced inflammation.
The health and regulation of adipose tissue is primarily maintained by the lymphatic system. [16] [17] [18] The lymphatic system serves as the conduit for immune cells (eg dendritic cells, monocytes, neutrophils and other leukocytes). These cells serve as the responders to tissue injury or pathogen invasion and are fundamental for the development of protective immune responses, including antibody and cellular immune responses. Lymph nodes are predominately embedded in adipose tissue depots, 19 thus are in a proximal location to continuously survey and monitor exposure of adipose tissue to potentially harmful pathogens and metabolites. 20, 21 Immune cells within lymph nodes can be recruited and activated to defend adipose tissue against damage, toxicity or impaired function. 22 In terms of immunity, obesity is characterized as a state of chronic low-grade inflammation caused by an inability to alleviate inflammation within adipose tissue. Hence, the lymphatic system is likely greatly impacted by this chronic inflammation, given the intimate association and cross-talk between adipose and lymphoid tissues. Therefore, any disease process that affects lymphoid tissues will also directly influence the development of immunity, including immune responses to pathogens, infections, cancers and vaccines. Overall, components of the lymphatic system must also contribute to obesityinduced comorbidities, yet there is very little understanding of the role the lymphatic system plays in obesity-linked disease manifestation.
Despite the spatial association and immune communication between adipose depots and lymph nodes, there remains critical knowledge gaps in our understanding of the molecular and cellular relationship between these two tissues. Given the continuous exposure of visceral draining lymph nodes to soluble inflammatory mediators released from immune cells infiltrating adipose tissue depots, we hypothesize that visceral lymph nodes represent an important sentinel of immune cell changes and subsequent dysregulation secondary to high-fat diet-induced obesity. In this study, we examined how high-fat diet-induced obesity influences lymph node micro-architecture and resident immune cell populations. In addition, we also investigated whether lymphatic response to diet-induced obesity is different between visceral and subcutaneous lymph nodes, given that visceral adiposity is highly associated with inflammation and metabolic disease, 7, 8 while subcutaneous is not. [9] [10] [11] 23, 24 We hypothesized that the immune cell populations within lymph nodes will be fundamentally different between those residing in visceral vs subcutaneous adipose tissue.
| METHODS

| Animals and diet
Male C57BL/6 mice (Jackson Laboratory, Bar Habor, Maine) (2-3 months, ~24 g) were single housed under controlled conditions (12:12 light-dark cycle, 50%-60% humidity, and 25°C) and allowed 1 week of acclimation before experiment start. Following acclimation mice were given free access to water and a standard CHOW or Western high-fat diet until termination at 7 weeks. Standard CHOW diet (CHOW:Harlan Teklad LM485, Madison, WI, USA) was 3.1 kcal/g with 18% kcal from fat (6% by weight of diet). The fats in the diet (from wheat, meal and animals fats) consisted of monounsaturated, polyunsaturated and saturated fatty acids (2.4%, 1.2% and 2.1% by weight of diet 
| Terminal procedures (blood collection and tissue harvesting)
Termination occurred after mice were on respective diets for 7 weeks.
Systemic blood was collected from anesthetized mice and serum was stored at −80°C. Visceral and inguinal adipose tissue and lymph nodes were excised and immediately stored in Hank's balanced salt solution (HBSS) or fixative. Inguinal adipose tissue is a subcutaneous fat depot located between external oblique and skin, whereas the visceral (mesenteric) adipose depot is located in the peritoneal cavity among the intestines and drains into the portal vein. 25 Bilateral subcutaneous lymph nodes were excised from the inguinal adipose depots, and visceral, mesenteric and lymph nodes were excised from the visceral depot. The spleen and thymi were also collected. Spleens were placed in HBSS or fixative and thymi were placed in fixative only.
| Separation of immune cells from stromal tissues
Following euthanasia and tissue harvest, lymph nodes and spleens were briefly stored in HBSS+5% foetal bovine serum (FBS) on ice, prior to filtering through a 40 μm cell strainer. Cell suspensions in HBSS+5%
FBS were centrifuged at 1.9856 g at 4°C for 5 minutes, supernatants were discarded, and cells from lymph nodes were re-suspended in 
| Flow cytometry
| Adipokine/cytokine assay
Serum insulin, leptin, resistin, interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1) and plasminogen activator inhibitor 1 (PAI-1 total) concentration were determined using commercial kits (EMD Millipore Corporation, Billerica, MA, USA) and analysed on a Luminex instrument (LX200; Millipore, Austin, TX, USA). 
| Histology and immunocytochemistry
| RESULTS
| Food intake, body weight and circulating factors
Cumulative kcal ingested over the 7-week experiment was significantly higher in HFD (n=5) mice compared with CHOW (n=5) ( Table 1, one-way ANOVA, LSD post-test; P=.0001). The increased intake was associated with a significant increase in body mass ( . Visceral lymph node of (A) CHOW and (B) HFD mouse. Subcutaneous lymph node of (C) CHOW and (D) HFD mouse. Lymph node area for an individual sample was the sum of four sections sliced across the largest mid-region portion of the lymph node. Lymph node area for an individual sample was the sum of four sections sliced across the largest mid-region portion of the lymph node. E, HFD significantly increased mean lymph node size of visceral lymph nodes (*=.004) but not subcutaneous compared to CHOW controls
| Lymph node histology
T A B L E 1 Cumulative kcals ingested over 7 weeks was significantly higher in HFD mice compared with CHOW and was associated with a significant increase in total body mass and total adiposity (*≤.045). Individual adipose tissue depots of HFD-fed mice were significantly larger (epididymal, perirenal, dorsal and inguinal) compared with CHOW controls (*≤.05). 
| Adipose tissue cell viability and immune population frequency
The visceral adipose depot has the greatest disposition for HFDinduced inflammation. Numerous previous studies in rodents 26 typically investigate epididymal adipose tissue, which drains into the systemic circulation, 27 not directly to the liver via hepatic portal vein. [28] [29] [30] Hence, although located in the abdominal cavity, epididymal adipose tissue is not the same as visceral that releases direct effluent into the liver. In addition, adipose tissue depots are inherently different in numerous ways, [31] [32] [33] [34] thus this study examines differences between immune cell populations of the true portal draining visceral adipose depot and the inguinal subcutaneous depot. In addition, this study extended the examination of depot differences to include evaluation of immune cell differences between lymph nodes embedded within the visceral and subcutaneous adipose depots.
The percentage of distinct immune cell populations was inherently different between the visceral and subcutaneous adipose depots, and furthermore, was differentially affected by HFD (n=7 per group).
Specifically, in CHOW-fed mice, the visceral adipose depot contained a significantly higher percentage of CD3 + T cells (Table 2, T 
| Lymph node cell viability and immune population frequency
We postulated that, similar to the visceral and subcutaneous adi- 
| Thymus and spleen
HFD caused a significant, ~50%, decrease in thymus area ( Figure 7A 
| Spleen cell viability and immune population frequency
Because HFD induced significant morphological alterations to normal splenic architecture, we further examined changes in the absolute numbers as well as relative percentages of normal immune cell sub- 
| DISCUSSION
Obesity, predominately visceral adiposity, links to numerous diseases including insulin resistance, diabetes and cardiovascular disease. 7, 8 Fundamental factors linking central adiposity, but not subcutaneous, to disease risks include heightened adipocyte associated inflammation restricting lymphocyte exit through efferent vessels. 40 Subsequently, the size of the draining lymph node expands considerably as result of influx and trapping of naive lymphocytes which enhances interactions with antigen presenting cells; this further drives hypertrophy with additional proliferation of antigen-specific lymphocytes. 41 Although inflammation incited by obesity is unlike traditional infections, we demonstrated here that lymph node hypertrophy is associated with adiposity-induced chronic low-grade inflammation. Our findings, however, are in opposition to previous studies demonstrating that obesity results in lymph node atrophy. 21, 42 In these studies, HFD caused a 50% or greater decrease in visceral lymph node size. We propose that differential outcomes result from longer diet durations (~10 weeks on HFD) 21, 42 and/or higher percent of fat in diet (~60%). them. Previous studies demonstrate that obesity alters immune cell populations within adipose tissue, especially fat within the visceral cavity. 6 The macrophage, part of the innate immune response, is among the best-characterized immune cell within adipose tissue and can both initiate immune response and assist in resolution. 43 ) of CHOW and HFD-fed animals. Haematoxylin and eosin (H&E) stain of CHOW and HFD mouse spleen (A) HFD altered spleen architecture (A), without altering the total area of the spleen (B). HFD significantly decreased overall spleen lymphoid follicle number, ~50%, compared with CHOW (*=.002) (C). In HFD animals, the total follicle area was not changed compared with control (D), but secondary lymphoid follicles in HFD animals significantly increased approximately 2-fold in number (*=.021) (E). Secondary follicle total area of HFD mice was also significantly increased ~2-fold (*=.001) compared with CHOW animals (F) Unlike the visceral adipose depot, the visceral lymph node contained the greatest number of Tregs, ~110 000, compared with subcutaneous depot, ~6000. This depot difference is likely due to the proximity and connection of the visceral lymph node to the gastrointestinal tract.
The visceral (mesenteric) lymph node is the key site of oral tolerance induction functioning as a firewall to preserve systemic ignorance to commensal organisms and food proteins. 71 Specifically, the Tregs within the visceral lymph node mediate oral tolerance to help prevent autoimmune and allergic responses and control the magnitude and duration of inflammatory responses. 72, 73 We propose the higher number of Tregs in the visceral lymph node of CHOW mice are pertinent to maintaining systemic health by preventing unwanted priming reactions. 71 HFD-induced decreases in visceral lymph node Tregs are likely associated with the increased macrophages and T-helper cells.
B cells also contribute to obesity-induced pathophysiology.
High-fat feeding increases the infiltration of B cells in the epididymal depot before significant accumulation of adipose tissue mass and likely precedes infiltration of T-cell types. 74 B-cell infiltration drives obesity-related comorbidities, such as insulin resistance, through cytokine production, T-cell modulation and antibody production. 75 We support previous studies indicating that HFD increases B cells within adipose tissue 74 and extend these results by demonstrating considerably greater increases in the visceral depot (increased ~75%) than subcutaneous depot (increased ~25%). Similarly and consistent with our immunocytochemistry, HFD increased B-cell numbers in the visceral lymph node by 45%, but no change occurred in the subcutaneous lymph node. We postulate that the increase in B cells within the visceral lymph node is due to proximity and connection to the gastrointestinal tract. B cells and plasma cell hyperplasia occur in response to antigenic stimulus that requires antibody production. 76 Such factors that trigger B-cell population and number increases include contact with microbiota, 77 bacterial peptidoglycan and endotoxins, ie lipopolysaccharide. 78 Gut permeability increases during obesity, which permits bacterial translocation from the gut lumen. 79, 80 This could contribute to enhance B-cell numbers in the visceral lymph nodes of HFD mice.
In addition to lymph nodes, we also examined larger lymphatic tissues, the thymus and the spleen. Unlike the lymph nodes, 7 weeks of HFD decreased the size of the thymus by ~50%. This, however, is consistent with previous studies that report 3-9 months of HFD (66% fat)
to reduce thymocyte counts and increase apoptosis of T cells. 81 Here, 
| LIMITATION
Diets used in this study were selected to induce significant body mass differences among the CHOW and HFD (Western) group. Hence, diet-induced obesity was fundamental to evaluating immune system alterations. Although this was accomplished, it is still worthwhile to note that a limitation of the study was the variations in macro-and micro-dietary composition among the two diets types (eg protein amount). Studies in the future should utilize purified diets that allow for a better comparison between CHOW and HFD (Western) diets that best matches for macro-and micro-nutrients between experimental diets.
